The development of the hybridoma technique in 1975 allowed for the mass production of monoclonal antibodies, a milestone that transformed modern clinical diagnostics and therapeutic medicine. This breakthrough emerged from the laboratory of Argentine-born biochemist César Milstein, whose lifelong study of antibody structure and immunological diversity redefined how scientists investigate the mechanisms of human disease.
Early Career and Education
Born in Bahía Blanca, Argentina, in 1927, Milstein completed his formal education at the University of Buenos Aires. He earned a Doctor of Sciences in Chemistry and initially served as a university teacher. In 1958, he moved to the University of Cambridge under a British Council grant to pursue a PhD under Malcolm Dixon. During this period, he collaborated with Frederick Sanger and secured a position at the Medical Research Council Laboratory of Molecular Biology, eventually obtaining British citizenship.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →The Hybridoma Breakthrough
Milstein’s primary research objective involved understanding how antibodies are generated and their structural variations. In 1975, while working with postdoctoral fellow Georges Köhler, he developed the hybridoma technique. This method enabled the creation of monoclonal antibodies, which function as specific probes to distinguish cell types and examine pathological pathways. Leonard Herzenberg later coined the term hybridoma while on sabbatical in Milstein's laboratory.
Contributions to Immunological Research
Beyond hybridoma technology, Milstein provided early evidence for precursor signal sequences in secreted polypeptides and mapped somatic hypermutation in immunoglobulin genes. His collaboration with Claudio Cuello applied these findings to neurological disorders, significantly enhancing the efficacy of diagnostic tests. Milstein also anticipated the integration of recombinant DNA technology in antibody engineering, which paved the way for modern, high-precision therapeutics.
Professional Honors
Milstein's influence earned him membership in numerous prestigious bodies, including the Royal Society, the National Academy of Sciences, and the Buenos Aires National Academy of Medicine. He received the 1984 Nobel Prize in Physiology or Medicine, alongside Niels Kaj Jerne and Georges Köhler. Other notable honors include the 1979 German Immunology Prize, the 1980 Robert Koch Prize, the 1981 Canada Gairdner International Award, and the 1993 diamond Konex award.
Fast facts
- Born: 1927, Bahía Blanca, Argentina
- Died: 24 March 2002, Cambridge, England
- Academic Degree: Doctor of Sciences in Chemistry
- Key Award: Nobel Prize in Physiology or Medicine (1984)
- Citizenship: United Kingdom, Argentina
- Field of Study: Immunology and biochemistry
- Professional Membership: Royal Society
Questions readers ask
What is the hybridoma technique?
It is a laboratory method developed by Milstein and Georges Köhler to produce monoclonal antibodies, which are essential for diagnostic testing and disease research.
Did Milstein work in countries other than Argentina?
Yes, he spent a significant portion of his career in the United Kingdom, specifically at the University of Cambridge and the Medical Research Council Laboratory of Molecular Biology.
Achievements
- Albert Lasker Award for Basic Medical Research — 1984
- Nobel Prize in Physiology or Medicine — 1984
- Copley Medal — 1989
- Wolf Prize in Medicine — 1980
- Affiliated with University of Buenos Aires
- Educated at University of Buenos Aires
- Worked as molecular biologist, immunologist and university teacher